SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong. 2022

Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.

The SARS-CoV-2 Omicron variant has led to a major wave of COVID-19 in Hong Kong between January and May 2022. Here, we used seroprevalence to estimate the combined incidence of vaccination and SARS-CoV-2 infection, including subclinical infection which were not diagnosed at the acute stage. The overall seropositive rate of IgG against receptor binding domain (anti-RBD IgG) increased from 52.2% in December 2021 to 89.3% in May 2022. The level of anti-RBD IgG was lowest in the 0-9 and ≥80 year-old age groups in May 2022. The seropositive rate of antibody against ORF8, which reflects the rate of prior infection, was 23.4% in May 2022. Our data suggest that although most individuals were either vaccinated or infected after the fifth wave, children and older adults remain most vulnerable. Public health measures should target these age groups in order to ameliorate the healthcare consequences of upcoming waves.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006723 Hong Kong The former British crown colony located off the southeast coast of China, comprised of Hong Kong Island, Kowloon Peninsula, and New Territories. The three sites were ceded to the British by the Chinese respectively in 1841, 1860, and 1898. Hong Kong reverted to China in July 1997. The name represents the Cantonese pronunciation of the Chinese xianggang, fragrant port, from xiang, perfume and gang, port or harbor, with reference to its currents sweetened by fresh water from a river west of it. Kowloon,New Territories,Hongkong
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D016036 Seroepidemiologic Studies EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. Seroprevalence,Seroepidemiologic Study,Seroepidemiological Study,Studies, Seroepidemiologic,Study, Seroepidemiologic,Seroepidemiological Studies,Seroprevalences,Studies, Seroepidemiological,Study, Seroepidemiological

Related Publications

Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
September 2022, Journal of travel medicine,
Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
April 2023, Nature communications,
Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
August 2023, Infection control and hospital epidemiology,
Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
June 2022, Zhonghua er ke za zhi = Chinese journal of pediatrics,
Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
August 2022, JAMA network open,
Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
March 2021, The journal of applied laboratory medicine,
Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
September 2020, The journal of applied laboratory medicine,
Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
December 2023, Salud publica de Mexico,
Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
February 2023, Pediatric blood & cancer,
Rosana Wing-Shan Poon, and Brian Pui-Chun Chan, and Wan-Mui Chan, and Carol Ho-Yan Fong, and Xiaojuan Zhang, and Lu Lu, and Lin-Lei Chen, and Joy-Yan Lam, and Vincent Chi-Chung Cheng, and Samson S Y Wong, and Kin-Hang Kok, and Kwok-Yung Yuen, and Kelvin Kai-Wang To
August 2022, Vaccines,
Copied contents to your clipboard!